The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
iSpecimen, which provides an online marketplace platform for biospecimen procurement, raised $18 million by offering 2.25 million shares at $8, the low end of the range of $8 to $10. At pricing, the company commands a fully diluted market value of about $52...read more
iSpecimen, which provides an online marketplace platform for biospecimen procurement, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $20 million by offering 2.2 million shares at a price range of $8 to $10. At the...read more
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals (OLMA), which soared 158% on its first day. New filings continued to pour in, priming the IPO...read more
US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week
The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Biospecimen marketplace iSpecimen prices $18 million IPO at $8 low end
iSpecimen, which provides an online marketplace platform for biospecimen procurement, raised $18 million by offering 2.25 million shares at $8, the low end of the range of $8 to $10. At pricing, the company commands a fully diluted market value of about $52...read more
Online biospecimen marketplace iSpecimen sets terms for $20 million IPO
iSpecimen, which provides an online marketplace platform for biospecimen procurement, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $20 million by offering 2.2 million shares at a price range of $8 to $10. At the...read more
US IPO Weekly Recap: Breast cancer biotech pops 158% in a 6 IPO week
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals (OLMA), which soared 158% on its first day. New filings continued to pour in, priming the IPO...read more